# UNITING DOCTORS - CLINICAL TRIAL MATCHING & RESEARCH COLLABORATION

**Last Updated**: November 8, 2025

---

## ğŸ”¬ Overview

Clinical Trial Matching connects patients with potentially life-changing research opportunities while enabling researchers to find eligible participants, accelerating medical breakthroughs and giving patients access to cutting-edge treatments.

### Core Mission

**Democratize access to clinical research by bridging the gap between patients seeking innovative treatments and researchers seeking participants.**

---

## ğŸ¯ Key Features

### 1. Comprehensive Clinical Trial Database

**Purpose**: Searchable database of active clinical trials worldwide

**Data Sources**:

- ClinicalTrials.gov (US NIH database)
- WHO International Clinical Trials Registry
- EU Clinical Trials Register
- Industry-sponsored trials
- Academic institution trials
- Investigator-initiated studies

**Trial Search Interface**:

```
ğŸ”¬ CLINICAL TRIAL SEARCH
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Find clinical trials that match your condition

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

SEARCH BY CONDITION:
ğŸ” Search: "Alpha-1 Antitrypsin Deficiency"

OR BROWSE BY:
[Category â–¼] [Location â–¼] [Phase â–¼] [Status â–¼]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

SEARCH RESULTS: 17 active trials for AATD

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸŒŸ FEATURED TRIAL

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ”¬ Novel Gene Therapy for AATD          â”‚
â”‚                                         â”‚
â”‚ Phase: Phase 2/3                        â”‚
â”‚ Status: ğŸŸ¢ Currently Recruiting         â”‚
â”‚ Sponsor: GeneTech Therapeutics          â”‚
â”‚ ID: NCT05849281                         â”‚
â”‚                                         â”‚
â”‚ OVERVIEW:                               â”‚
â”‚ Investigating one-time gene therapy to â”‚
â”‚ restore alpha-1 antitrypsin production  â”‚
â”‚ in patients with severe AATD.          â”‚
â”‚                                         â”‚
â”‚ ELIGIBILITY HIGHLIGHTS:                 â”‚
â”‚ âœ“ Ages 18-65                            â”‚
â”‚ âœ“ Diagnosed AATD (ZZ or SZ genotype)   â”‚
â”‚ âœ“ FEV1 30-65% predicted                 â”‚
â”‚ âœ— Current smokers excluded              â”‚
â”‚ âœ— Prior gene therapy excluded           â”‚
â”‚                                         â”‚
â”‚ LOCATIONS: 24 sites across US           â”‚
â”‚ Nearest: University Hospital (12 miles) â”‚
â”‚                                         â”‚
â”‚ DURATION: 18 months participation       â”‚
â”‚ VISITS: Screening + 8 follow-up visits  â”‚
â”‚                                         â”‚
â”‚ COMPENSATION: Travel expenses covered   â”‚
â”‚                                         â”‚
â”‚ ğŸ“Š MATCH SCORE: 87% based on your      â”‚
â”‚    profile (Create profile for scores)  â”‚
â”‚                                         â”‚
â”‚ [View Full Details] [Check Eligibility] â”‚
â”‚ [Contact Study Team] [Save for Later]  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

OTHER MATCHING TRIALS:

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š New Augmentation Therapy Study       â”‚
â”‚ Phase 3 | Recruiting | 48 sites        â”‚
â”‚ Match: 92% | [View Details]            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ« Long-term AATD Outcomes Registry     â”‚
â”‚ Observational | Recruiting | All US    â”‚
â”‚ Match: 95% | [View Details]            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§¬ AATD Genetic Modifiers Study         â”‚
â”‚ Observational | Recruiting | Virtual   â”‚
â”‚ Match: 88% | [View Details]            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

[View All 17 Trials]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ”” TRIAL ALERTS

Get notified when new trials match your profile:
â–¡ Email alerts
â–¡ Push notifications
â–¡ Weekly digest

[Set Up Alerts]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“š HELPFUL RESOURCES:

â€¢ Understanding Clinical Trial Phases
â€¢ Questions to Ask Before Enrolling
â€¢ Clinical Trial Myths vs Facts
â€¢ Patient Rights in Research
â€¢ How Clinical Trials Work

[Learn More About Clinical Trials]
```

**Trial Information Includes**:

- Study purpose and design
- Eligibility criteria (inclusion/exclusion)
- Study locations and contact info
- Duration and time commitment
- Procedures involved
- Potential risks and benefits
- Compensation (if any)
- Results from earlier phases
- Principal investigator info

---

### 2. Intelligent Patient Matching

**Purpose**: Match patients to relevant trials based on their medical profile

**How It Works**:

**Step 1: Create Health Profile**

```
ğŸ“‹ CREATE YOUR CLINICAL TRIAL PROFILE
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Help us find trials that match your health profile.
All information is private and encrypted.

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

BASIC INFORMATION:
Age: [Enter age]
Location: [ZIP code or city]
Willing to travel: [Within 25 miles â–¼]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

PRIMARY CONDITION:
ğŸ” Select condition: "Alpha-1 Antitrypsin Deficiency"

Diagnosis date: [MM/YYYY]
Severity: â—‹ Mild â— Moderate â—‹ Severe

AATD-Specific Information:
Genotype: [ZZ â–¼]
FEV1: [52% predicted]
Currently on augmentation therapy: â˜‘ Yes
Other lung conditions: â˜‘ COPD â–¡ Asthma

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

OTHER MEDICAL HISTORY:
[+ Add other conditions]
[+ Add current medications]
[+ Add past surgeries]
[+ Add allergies]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

LIFESTYLE:
Smoking status: â—‹ Current â— Former â—‹ Never
Alcohol use: â—‹ Yes â— No
Employment status: [Employed â–¼]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

TRIAL PREFERENCES:
Interested in:
â˜‘ Drug trials
â˜‘ Device trials
â˜‘ Behavioral trials
â˜‘ Observational studies
â˜‘ Genetic studies

Trial phases willing to consider:
â–¡ Phase 1 (first-in-human, small, safety)
â˜‘ Phase 2 (larger, efficacy testing)
â˜‘ Phase 3 (large, confirmatory)
â˜‘ Phase 4 (post-approval, long-term)

[Save Profile] [Find Matching Trials]
```

**Step 2: AI-Powered Matching**

- Parse eligibility criteria from trial listings
- Match against patient profile
- Calculate compatibility score (0-100%)
- Rank trials by relevance
- Highlight potential disqualifiers

**Step 3: Match Results**

```
ğŸ¯ YOUR TRIAL MATCHES
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Based on your profile, we found 17 trials

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

EXCELLENT MATCHES (90%+ compatible)

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š New Augmentation Therapy Study       â”‚
â”‚ Match Score: 95%                        â”‚
â”‚                                         â”‚
â”‚ WHY YOU MATCH:                          â”‚
â”‚ âœ“ AATD ZZ genotype (required)           â”‚
â”‚ âœ“ FEV1 in range (30-70% needed)        â”‚
â”‚ âœ“ Currently on therapy (required)       â”‚
â”‚ âœ“ Age 18-65 (you're 47)                â”‚
â”‚ âœ“ Location: Site 12 miles away          â”‚
â”‚                                         â”‚
â”‚ POTENTIAL BARRIERS:                     â”‚
â”‚ âš ï¸ Requires monthly visits (18 months)  â”‚
â”‚    [View full visit schedule]           â”‚
â”‚                                         â”‚
â”‚ [View Full Details] [Express Interest]  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ« Long-term AATD Outcomes Registry     â”‚
â”‚ Match Score: 92%                        â”‚
â”‚                                         â”‚
â”‚ MINIMAL TIME COMMITMENT:                â”‚
â”‚ â€¢ Observational study (no intervention) â”‚
â”‚ â€¢ Annual surveys only                   â”‚
â”‚ â€¢ Some can be done remotely             â”‚
â”‚                                         â”‚
â”‚ [View Full Details] [Express Interest]  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

GOOD MATCHES (70-89% compatible)

[Show 8 more trials]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

POSSIBLE MATCHES (50-69% compatible)

These trials have some eligibility requirements
that may not match your profile. Review carefully.

[Show 7 more trials]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ”” GET ALERTS FOR NEW TRIALS

We'll notify you when new trials match your profile.

[Enable Alerts] [Refine Profile]
```

---

### 3. Direct Study Team Communication

**Purpose**: Facilitate connections between patients and research coordinators

**Contact Flow**:

```
ğŸ“§ EXPRESS INTEREST IN TRIAL
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Trial: Novel Gene Therapy for AATD
ID: NCT05849281

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

CONTACT STUDY TEAM

Your interest will be sent to the study
coordinator, who will contact you to discuss
eligibility and next steps.

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

PREFERRED CONTACT METHOD:
â— Email: [your-email@example.com]
â—‹ Phone: [Enter phone number]

Best time to reach you:
â–¡ Weekday mornings
â˜‘ Weekday afternoons
â–¡ Weekday evenings
â˜‘ Weekends

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

QUESTIONS FOR STUDY TEAM (Optional):

[Text box]
Example questions:
â€¢ How many participants have enrolled so far?
â€¢ What is the time commitment per visit?
â€¢ Are there any out-of-pocket costs?
â€¢ When do you expect to start enrollment?

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

SHARE YOUR PROFILE (Recommended):

Sharing your health profile helps the study
team quickly determine if you're eligible.

â˜‘ Share my profile with this study team
   (Your profile will only be sent to this specific
    study. You control what information is shared.)

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

[Send Interest] [Cancel]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ”’ PRIVACY: Your contact information is only
shared with the specific study team you contact.
Study teams are verified and bound by research
ethics regulations.
```

**Follow-Up Tracking**:

```
ğŸ“Š MY TRIAL APPLICATIONS
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Track your clinical trial inquiries and status

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ACTIVE INQUIRIES (3)

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’Š New Augmentation Therapy Study       â”‚
â”‚ Status: âœ… Screening Scheduled          â”‚
â”‚ Next Step: Phone screen Nov 15, 2PM     â”‚
â”‚ Contact: Sarah Johnson, Study Coordinatorâ”‚
â”‚ [View Details] [Message Coordinator]    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ”¬ Novel Gene Therapy for AATD          â”‚
â”‚ Status: ğŸ“ Awaiting Response             â”‚
â”‚ Contacted: November 5                    â”‚
â”‚ [View Details] [Follow Up]              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ« Long-term AATD Outcomes Registry     â”‚
â”‚ Status: âœ… Enrolled!                     â”‚
â”‚ Enrollment Date: October 28              â”‚
â”‚ Next Survey Due: January 2026           â”‚
â”‚ [View Study Portal] [Contact Team]      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

PAST INQUIRIES (2)

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ§¬ AATD Genetic Modifiers Study         â”‚
â”‚ Status: âŒ Not Eligible                  â”‚
â”‚ Reason: Required specific genotype      â”‚
â”‚ Date: October 15                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

[View All]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“§ MESSAGES (1 Unread)

New message from Sarah Johnson (Augmentation Study)
"Hi! Confirming your phone screening tomorrow at 2PM..."
[Read Message]
```

---

### 4. Researcher Patient Recruitment Tools

**Purpose**: Help researchers find eligible participants

**Researcher Dashboard**:

```
ğŸ‘¥ RESEARCHER RECRUITMENT DASHBOARD
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Study: Novel Gene Therapy for AATD
ID: NCT05849281
PI: Dr. Jennifer Martinez

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“Š RECRUITMENT STATUS

Target Enrollment: 120 patients
Current Enrollment: 47 patients (39%)
Pipeline: 23 patients in screening

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ¯ INTERESTED PATIENTS (15 new this week)

Sort by: [Match Score â–¼] [Location â–¼] [Date â–¼]

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ PATIENT #UD-48291                       â”‚
â”‚ Match Score: 95%                        â”‚
â”‚                                         â”‚
â”‚ KEY ELIGIBILITY FACTORS:                â”‚
â”‚ âœ“ Age: 47 (range 18-65)                â”‚
â”‚ âœ“ AATD ZZ genotype (required)           â”‚
â”‚ âœ“ FEV1: 52% (range 30-65%)             â”‚
â”‚ âœ“ Non-smoker (required)                 â”‚
â”‚ âœ“ Location: 12 miles from site          â”‚
â”‚                                         â”‚
â”‚ POTENTIAL CONCERNS:                     â”‚
â”‚ âš ï¸ Currently on augmentation therapy    â”‚
â”‚    (washout period required?)           â”‚
â”‚                                         â”‚
â”‚ INTEREST EXPRESSED: November 5          â”‚
â”‚ CONTACT METHOD: Email preferred         â”‚
â”‚                                         â”‚
â”‚ QUESTIONS ASKED:                        â”‚
â”‚ "How many participants enrolled?"       â”‚
â”‚ "What's the time commitment per visit?" â”‚
â”‚                                         â”‚
â”‚ [View Full Profile] [Contact Patient]   â”‚
â”‚ [Schedule Pre-Screen] [Mark Not Eligible]â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

[View All 15 Interested Patients]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“¢ RECRUITMENT CAMPAIGNS

ACTIVE CAMPAIGNS:
â€¢ Targeted email to AATD community (sent to 847 matches)
  Open rate: 42% | Click rate: 18% | Conversions: 7

â€¢ Social media awareness campaign (ongoing)
  Reach: 3,200 | Engagement: 245 | Inquiries: 4

[Create New Campaign] [View Analytics]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“ˆ RECRUITMENT ANALYTICS

[Graph showing enrollment over time]

Top referral sources:
1. Patient profile matching (67%)
2. Direct search (21%)
3. Physician referral (9%)
4. Social media (3%)

[View Detailed Analytics]
```

**Targeted Recruitment**:

- Search patient profiles by eligibility criteria
- Send recruitment messages to matched patients
- Track response rates and conversion
- A/B test recruitment messaging
- Coordinate with multiple study sites

---

### 5. Clinical Trial Education

**Purpose**: Help patients understand clinical trials and make informed decisions

**Educational Resources**:

```
ğŸ“ CLINICAL TRIALS 101
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Everything you need to know about participating
in medical research

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“š GETTING STARTED:

â–¡ [What is a Clinical Trial?]
  Learn the basics of medical research

â–¡ [Why Participate in Research?]
  Benefits and considerations

â–¡ [Clinical Trial Phases Explained]
  Phase 1, 2, 3, 4 - what's the difference?

â–¡ [Am I Eligible?]
  Understanding inclusion/exclusion criteria

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

â“ COMMON QUESTIONS:

â€¢ Is participating in a trial safe?
â€¢ Will I get paid?
â€¢ Can I leave a trial if I change my mind?
â€¢ What is informed consent?
â€¢ What are placebos and will I get one?
â€¢ How long do trials last?
â€¢ Who pays for trial-related care?

[View All FAQs (47 questions)]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ¥ VIDEO LIBRARY:

[â–¶ï¸ Clinical Trials Explained (5 min)]
[â–¶ï¸ Patient Success Stories]
[â–¶ï¸ Understanding Informed Consent]
[â–¶ï¸ What to Expect in a Trial]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“‹ BEFORE YOU ENROLL CHECKLIST:

Questions to ask the study team:
â–¡ What is the purpose of this study?
â–¡ What procedures are involved?
â–¡ How long will I participate?
â–¡ What are the potential risks?
â–¡ What are the potential benefits?
â–¡ What are my alternatives?
â–¡ Can I see the informed consent form?
â–¡ Who will cover the costs?
â–¡ Who do I contact with questions?
â–¡ Can I bring a support person?

[Download Full Checklist]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“– YOUR RIGHTS AS A PARTICIPANT:

â€¢ Right to informed consent
â€¢ Right to withdraw at any time
â€¢ Right to ask questions
â€¢ Right to privacy (HIPAA protection)
â€¢ Right to know about risks
â€¢ Right to compensation for injury
â€¢ Right to trial results

[Learn More About Patient Rights]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ‘¥ PATIENT STORIES:

"Participating in an AATD trial gave me access
to a treatment years before it was approved.
It changed my life." - Sarah, Trial Participant

[Read More Stories]
```

**Decision Support Tools**:

- **Trial Comparison Tool**: Compare multiple trials side-by-side
- **Risk-Benefit Calculator**: Weigh pros and cons
- **Family Discussion Guide**: Help explain trials to loved ones
- **Informed Consent Explainer**: Simplify consent forms

---

### 6. Trial Results & Data Sharing

**Purpose**: Share research outcomes with community

**Results Publication**:

```
ğŸ“Š TRIAL RESULTS: GENE THERAPY FOR AATD
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Study ID: NCT05849281
Status: âœ… Completed
Publication Date: October 2025

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

PATIENT-FRIENDLY SUMMARY:

This study tested a new one-time gene therapy
for AATD. The therapy aims to restore the body's
ability to make alpha-1 antitrypsin protein.

WHAT THE STUDY FOUND:

âœ… PRIMARY OUTCOME: Met successfully
   After 12 months, 78% of patients showed
   sustained AAT levels in the protective range
   (>11 Î¼M).

âœ… SECONDARY OUTCOMES:
   â€¢ 63% showed improved lung function (FEV1)
   â€¢ 84% had fewer respiratory infections
   â€¢ 71% reported improved quality of life

âš ï¸ SAFETY:
   Most side effects were mild (fever, headache).
   3 patients had moderate reactions requiring
   observation. No serious adverse events.

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

WHAT THIS MEANS:

This gene therapy shows promise as a potential
one-time treatment for AATD. Results suggest
it could reduce or eliminate the need for weekly
augmentation therapy infusions.

NEXT STEPS:

A larger Phase 3 trial will begin in early 2026
to confirm these results. FDA approval is
estimated 2027-2028 if Phase 3 is successful.

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“„ FULL RESULTS:

â€¢ [Patient-Friendly Summary] (PDF)
â€¢ [Scientific Publication] (Peer-reviewed)
â€¢ [Study Protocol] (Technical)
â€¢ [Statistical Analysis Plan]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ’¬ COMMUNITY DISCUSSION:

Join the conversation about these results:
[View Discussion Thread (147 comments)]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ”” RELATED TRIALS:

Based on these results, you may be interested in:
â€¢ Phase 3 Gene Therapy Trial (Opening 2026)
â€¢ Long-term Follow-up Study (Recruiting)

[View Related Trials]
```

**Community-Contributed Data**:

- Patient-reported outcomes from trials
- Long-term follow-up beyond study end
- Quality of life data
- Treatment adherence insights
- Real-world effectiveness

---

### 7. Physician Referral Network

**Purpose**: Enable physicians to refer patients to relevant trials

**Physician Referral Portal**:

```
ğŸ‘¨â€âš•ï¸ PHYSICIAN TRIAL REFERRAL SYSTEM
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Refer your patients to clinical trials

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

QUICK REFERRAL:

Patient Condition: [AATD â–¼]
Patient Age: [47]
Key Criteria: [Select...]
Location: [ZIP code]

[Find Matching Trials]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

RECENT REFERRALS:

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Patient: J.S. (ID: #28471)              â”‚
â”‚ Referred to: Gene Therapy Trial         â”‚
â”‚ Status: Screened - Eligible - Enrolled  â”‚
â”‚ Date: October 12                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Patient: M.K. (ID: #28399)              â”‚
â”‚ Referred to: Outcomes Registry          â”‚
â”‚ Status: Enrolled                         â”‚
â”‚ Date: September 28                       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

[View All Referrals]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“Š YOUR REFERRAL METRICS:

â€¢ Total Referrals: 23
â€¢ Successfully Enrolled: 18 (78%)
â€¢ Currently Screening: 3
â€¢ Not Eligible: 2

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ“ EARN CME CREDITS:

Earn CME for referring patients to trials
[Learn More]
```

**Benefits for Physicians**:

- Track patient progress in trials
- Earn referral fees (where allowed)
- Earn CME credits
- Stay informed of new research
- Collaborate with researchers

---

### 8. Global Trial Access

**Purpose**: Connect patients to international trials

**International Trial Search**:

```
ğŸŒ INTERNATIONAL CLINICAL TRIALS
â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

Search trials worldwide, including:
â€¢ United States (ClinicalTrials.gov)
â€¢ European Union (EU CTR)
â€¢ United Kingdom (ISRCTN)
â€¢ Japan (JMACCT)
â€¢ China (ChiCTR)
â€¢ Australia (ANZCTR)
â€¢ WHO Global Registry

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

GLOBAL AATD TRIALS: 47 active worldwide

FILTER BY REGION:
â–¡ North America (17 trials)
â–¡ Europe (23 trials)
â–¡ Asia (5 trials)
â–¡ Australia (2 trials)

WILLING TO TRAVEL INTERNATIONALLY?
Learn about:
â€¢ Medical tourism considerations
â€¢ Travel expense coverage
â€¢ Visa requirements
â€¢ Language support
â€¢ Housing assistance

[Search International Trials]

â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”

ğŸ‡¬ğŸ‡§ FEATURED: UK Gene Editing Trial

Phase 1/2 trial using CRISPR to correct
AATD genetic mutation. Seeking ZZ patients
ages 18-50.

â€¢ Travel and housing covered
â€¢ English-speaking staff
â€¢ 6-month commitment

[Learn More]
```

---

## ğŸ”’ Privacy & Ethics

### Patient Privacy

- De-identified profiles shared with researchers
- Patient controls what information is shared
- HIPAA-compliant data handling
- Secure communication channels

### Ethical Standards

- All trials must be IRB-approved
- Informed consent required
- Right to withdraw anytime
- No coercion or undue influence
- Fair compensation (not inducement)

### Researcher Verification

- Verify institutional affiliation
- Confirm IRB approval
- Review study protocols
- Monitor recruitment practices

---

## ğŸ’° Revenue Model

### Free for Patients

- Trial search and matching free
- Educational resources free
- Communication with study teams free
- Mission: No barriers to research access

### Researcher Services

- **Trial Listing Fee**: $500-2,000/month per trial
- **Enhanced Recruitment**: $2,000-5,000/month
  - Featured placement
  - Targeted patient outreach
  - Advanced analytics
- **Per-Patient Referral**: $200-500 per enrolled patient
- **Recruitment Campaign Services**: $5,000-20,000
  - Custom recruitment strategies
  - Social media campaigns
  - Physician outreach

### Institutional Licenses

- **Academic Medical Centers**: $10,000-25,000/year
  - All trials listed
  - Recruitment tools access
  - Analytics dashboard
  - Physician referral system

- **Contract Research Organizations (CROs)**: $25,000-100,000/year
  - Manage multiple studies
  - White-label recruitment tools
  - API access

- **Pharmaceutical Companies**: Custom pricing
  - Enterprise recruitment platform
  - Dedicated support
  - Regulatory compliance assistance

---

## ğŸ“Š Success Metrics

### Patient Impact

- Patients matched to trials
- Successful enrollments
- Geographic reach
- Underrepresented populations included
- Patient satisfaction scores

### Research Impact

- Trials meeting enrollment goals
- Time to full enrollment
- Screen failure rate reduction
- Diversity of trial populations
- Number of breakthrough therapies advanced

### Platform Growth

- Trial listings (target: 10,000+ global trials)
- Patient profiles created
- Active researchers using platform
- Physician referrals
- Educational resource views

---

## ğŸš€ Implementation Roadmap

### Phase 1 (Year 1): Foundation

- ClinicalTrials.gov integration
- Basic trial search and matching
- Patient profile creation
- Study team messaging
- Educational content library

**Target Outcomes**:

- 1,000 trials listed
- 500 patient profiles
- 50 successful enrollments

### Phase 2 (Year 2): Growth

- International trial databases
- Advanced matching algorithms
- Physician referral network
- Trial results publication
- Mobile app

**Target Outcomes**:

- 5,000 trials listed
- 5,000 patient profiles
- 500 enrollments
- 100 physician partners

### Phase 3 (Year 3): Scale

- AI-powered matching
- Predictive analytics
- Virtual trials support
- Decentralized trial tools
- Global expansion (translation)

**Target Outcomes**:

- 10,000+ trials listed
- 25,000+ patient profiles
- 2,500 enrollments/year
- 500+ institutional partners

---

**"Accelerating cures by connecting patients with researchâ€”because every patient deserves access to hope and every researcher deserves access to participants."**
